{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:09:21Z","timestamp":1773281361925,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/icu.0b013e3283541eb6","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T10:53:57Z","timestamp":1338980037000},"page":"276-279","source":"Crossref","is-referenced-by-count":20,"title":["Gene therapy for corneal dystrophies and disease, where are we?"],"prefix":"10.1097","volume":"23","author":[{"given":"Keryn A.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210206","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.exer.2010.06.020","article-title":"AAV serotype influences gene transfer in corneal stroma in vivo.","volume":"91","author":"Sharma","year":"2010","journal-title":"Exp Eye Res"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1463-5224.2010.00813.x","article-title":"Gene delivery in the equine cornea: a novel therapeutic strategy.","volume":"13","author":"Buss","year":"2010","journal-title":"Vet Ophthalmol"},{"key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/gt.2010.159","article-title":"Matrix metalloproteinase 14 overexpression reduces corneal scarring.","volume":"18","author":"Galiacy","year":"2011","journal-title":"Gene Ther"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Lebers congenital amaurosis.","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1442-9071.2010.02261.x","article-title":"Lentivirus-mediated gene transfer of interleukin 10 to the ovine and human cornea.","volume":"38","author":"Parker","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R7-9-20210206","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0004-27492010000500012","article-title":"Gene transfer to primary corneal epithelial cells with an integrating lentiviral vector.","volume":"73","author":"De Oliveira","year":"2010","journal-title":"Arq Bras Oftalmol"},{"key":"R8-9-20210206","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1167\/iovs.09-4569","article-title":"Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene.","volume":"51","author":"Saghizadeh","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-9-20210206","first-page":"1389","article-title":"Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.","volume":"16","author":"Zhou","year":"2010","journal-title":"Mol Vis"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: a delivery platform for ocular therapeutics.","volume":"62","author":"De la Fuente","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"R11-9-20210206","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.biomaterials.2009.10.031","article-title":"Ultrapure chitosan oligomers as carriers for corneal gene transfer.","volume":"31","author":"Klausner","year":"2010","journal-title":"Biomaterials"},{"key":"R12-9-20210206","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nano.2011.01.006","article-title":"Polyethylenimine-conjugated gold nanoparticles: gene transfer potential and low toxicity in the cornea.","volume":"7","author":"Sharma","year":"2011","journal-title":"Nanomedicine"},{"key":"R13-9-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.preteyeres.2011.09.001","article-title":"Gene therapy in the cornea: 2005-present.","volume":"31","author":"Mohan","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","article-title":"Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis.","volume":"117","author":"Pisanti","year":"2011","journal-title":"Blood"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/156652411794859241","article-title":"Decorin biology, expression, function and therapy in the cornea.","volume":"11","author":"Mohan","year":"2011","journal-title":"Curr Mol Med"},{"key":"R18-9-20210206","first-page":"565","article-title":"Role of transforming growth factor beta in corneal function, biology and pathology.","volume":"10","author":"Tandon","year":"2010","journal-title":"Curr Mol Med"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2010.05.013","article-title":"Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.","volume":"91","author":"Mohan","year":"2010","journal-title":"Exp Eye Res"},{"key":"R20-9-20210206","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1167\/iovs.11-7357","article-title":"Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.","volume":"52","author":"Mohan","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1093\/hmg\/ddr379","article-title":"Keratin disorders: from gene to therapy.","volume":"20","author":"McLean","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exer.2011.07.001","article-title":"Experimental gene transfer to the corneal endothelium.","volume":"95","author":"Kampik","year":"2012","journal-title":"Exp Eye Res"},{"key":"R23-9-20210206","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/gt.2011.20","article-title":"Antiapoptotic gene therapy prolongs survival of corneal endothelial cells during storage.","volume":"18","author":"Fuchsluger","year":"2011","journal-title":"Gene Ther"},{"key":"R24-9-20210206","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/hum.2010.079","article-title":"Corneal endothelial cells are protected from apoptosis by gene therapy.","volume":"22","author":"Fuchsluger","year":"2011","journal-title":"Hum Gene Ther"},{"key":"R25-9-20210206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1442-9071.2009.02179.x","article-title":"Gene therapy for diseases of the cornea - a review.","volume":"38","author":"Williams","year":"2010","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICU.0b013e3283541eb6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T23:31:13Z","timestamp":1714001473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00055735-201207000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e3283541eb6","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}